Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Hisamitsu Pharmaceutical Co., Inc. is currently managing 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 7 distinct examiners, indicating that each examiner is handling exactly a single case for the company. This broad distribution suggests that the company's prosecution results are not dependent on the discretion of any single individual.
The portfolio is spread across 6 distinct art units, which reflects a diverse range of technical focuses within the pharmaceutical sector. MARK V STEVENS is identified as the busiest examiner, although he is responsible for only 1 busiest examiner pending action. This confirms that the workload is evenly dispersed across the distinct examiners currently assigned to the company's files.
For practitioners, the fact that pending office actions are spread across 6 distinct art units implies that the applicant must manage a variety of examination cultures and standards. The high ratio of art units to pending actions suggests that the Biotechnology & Pharmaceuticals inventions being pursued are technically varied. This decentralized prosecution environment requires a flexible strategy to address the different requirements of each art unit and examiner involved.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| Double-patenting + other | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEVENS, MARK V | 1 | 65.5% | +41.6% |
| CHI, AMANDA LYNN | 1 | — | — |
| MALATEK, KATHERYN A | 1 | 86.7% | +43.0% |
| KUMAR, RAKESH | 1 | 57.2% | +28.2% |
| SOROUSH, LAYLA | 1 | 40.5% | +43.4% |
| NGUYEN, NGOC-ANH THI | 1 | 28.1% | +49.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18292103 | MICRONEEDLE PATCH | MALATEK, KATHERYN A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17433289 | TRANSDERMAL PATCH | NGUYEN, NGOC-ANH THI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270760 | PACKAGING BAG AND PATCH PACKAGING PRODUCT | KUMAR, RAKESH | 14d |
| 18941163 | PATCH | STEVENS, MARK V | — |
| 18292103 | MICRONEEDLE PATCH | MALATEK, KATHERYN A | — |
| 17796921 | DICLOFENAC SODIUM CONTAINING PATCH | SOROUSH, LAYLA | — |
| 17433289 | TRANSDERMAL PATCH | NGUYEN, NGOC-ANH THI | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 3741 | 1 |
| 3651 | 1 |
| 1622 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18941163 | PATCH | STEVENS, MARK V | — | §112DP | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18705656 | ADHESIVE PATCH WITH COVER MATERIAL | CHI, AMANDA LYNN | 1613 | §103 | Final Rejection | 16d | Pending | Apr 29, 2024 |
| 18292103 | MICRONEEDLE PATCH | MALATEK, KATHERYN A | 3741 | §103 | Final Rejection | — | Pending | Jan 25, 2024 |
| 18270760 | PACKAGING BAG AND PATCH PACKAGING PRODUCT | KUMAR, RAKESH | 3651 | §103 | Final Rejection | 14d | Pending | Jul 03, 2023 |
| 17796921 | DICLOFENAC SODIUM CONTAINING PATCH | SOROUSH, LAYLA | 1622 | §103DP | Non-Final OA | — | Pending | Aug 02, 2022 |
| 17433289 | TRANSDERMAL PATCH | NGUYEN, NGOC-ANH THI | 1615 | §103 | Final Rejection | — | Pending | Aug 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial